Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Semler Scientific, Inc. securities between March 10, 2021, and April 15, 2025, due to alleged misleading statements and undisclosed investigations by the DOJ [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Semler Scientific failed to disclose a material investigation by the DOJ regarding violations of the False Claims Act, leading to materially false and misleading public statements [5]. - Investors who purchased Semler Scientific securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must file a motion with the court by October 28, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - A class action lawsuit has been filed against Snap Inc. for allegedly misleading investors about its business prospects, particularly regarding advertising revenue and growth expectations during the specified period [1][2]. Allegations - The complaint asserts that Snap's management created a false impression of having reliable information about expected advertising revenue while downplaying macroeconomic instability [2]. - Snap's optimistic reports on advertising growth were misleading, as they were overly reliant on the company's execution capabilities, which were already faltering [2]. Financial Results and Impact - On August 5, 2025, Snap reported a slowdown in advertising revenue growth, attributing it to issues with its ad platform, the timing of Ramadan, and minor changes [3]. - Following this announcement, Snap's stock price dropped from $9.39 per share to $7.78 per share, marking a decline of over 17% [3]. Class Action Participation - Shareholders may be eligible to participate in the class action against Snap Inc. and can contact Robbins LLP for more information [3]. - Individuals interested in serving as lead plaintiffs are encouraged to reach out, although participation in the case is not required for recovery eligibility [3]. About Robbins LLP - Robbins LLP is recognized for its work in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [4].

LOS ANGELES, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming October 21, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR NUTEX INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECO ...

LOS ANGELES, Aug. 29, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to PubMatic, Inc. ("PubMatic" or the "Company") (NASDAQ: PUBM) have opportunity to lead the securities fraud class action lawsuit.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PUBMATIC, INC. (PUBM), CLICK HERE BEFORE OCTOBER 20, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. What Is The Lawsuit About? The complaint filed alleges that, between Fe ...

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in RxSight, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/rxsight-inc-class-action-lawsuit. Investors have until September 22, 2025, to ask the Court to ...

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Vital Energy, Inc. (NYSE: VTLE)’s sale to Crescent Energy Company for 1.9062 shares of Crescent Class A common stock for each share of Vital common stock. If you are a Vital shareholder, click here to learn more about your rights and options. scPharmaceutical ...

NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fiserv, Inc. ("Fiserv, Inc." or the "Company") (NYSE: FI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fiserv, Inc. investors who were adversely affected by alleged securities fraud between July 24, 2024 and July 22, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/fiserv-inc-lawsuit-submission-form? ...

NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of James Hardie Industries plc ("James Hardie" or the "Company") (NYSE: JHX).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether James Hardie and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On Aug ...

NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. ("Align" or the "Company") (NASDAQ: ALGN).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.  The investigation concerns whether Align and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On July 30, 2025, Ali ...

NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fly-E Group, Inc. ("Fly-E" or the "Company") (NASDAQ: FLYE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Fly-E and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On August 13, 2025, The Bear ...